Search
Barinthus Biotherapeutics PLC
BRNSAdd to Watchlist
0.558USD
+0.007+1.29%
Close 07-31 16:00（ET）Quotes delayed by 15 min
22.79MMarket Cap
LossP/E TTM
BRNS Cash Flow Statement
You can access the annual and quarterly cash flow statements of Barinthus Biotherapeutics PLC to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FAQs
What is operating cash flow?
Operating cash flow is the cash generated or used by a company's core business operations. It adjusts net income for non-cash items and working capital changes, such as depreciation, receivables, inventory, and payables. Strong operating cash flow can indicate that the business is converting sales and earnings into real cash.
How Much Operating Cash Flow Did Barinthus Biotherapeutics PLC Generate?
Barinthus Biotherapeutics PLC generated -47.98M in operating cash flow in fiscal 2025, reflecting cash generated from its core business operations.
How Did Barinthus Biotherapeutics PLC's Operating Cash Flow Change Year Over Year?
Barinthus Biotherapeutics PLC's operating cash flow increased by -65.79% year over year.
What is investing cash flow?
Investing cash flow shows cash used for or generated from investment-related activities, such as capital expenditures, purchases or sales of investments, acquisitions, and asset disposals. Negative investing cash flow is not always bad, because it can reflect spending on future growth, but investors should check whether those investments support long-term returns.
How Much Does Barinthus Biotherapeutics PLC Spend on Capital Expenditures?
Barinthus Biotherapeutics PLC spent 37.00K on capital expenditures in the most recent quarter。
What is financing cash flow?
Financing cash flow shows how a company raises capital or returns capital to investors and creditors. It can include debt issuance, debt repayment, share issuance, share repurchases, dividend payments, and lease financing. Positive financing cash flow may show new capital raised, while negative financing cash flow may reflect debt repayment, dividends, or buybacks.
How Has Barinthus Biotherapeutics PLC's Financing Cash Flow Changed?
Barinthus Biotherapeutics PLC used 2.00K in financing activities in the latest quarter.
What is free cash flow and why does it matter for BRNS?
Free cash flow is the cash a company has left after funding the capital spending needed to maintain or grow the business. It is often used to assess financial flexibility, debt repayment capacity, dividend sustainability, buyback potential, and valuation quality. Investors should compare free cash flow with net income, revenue growth, and capital expenditures.
What was Barinthus Biotherapeutics PLC’s free cash flow in the latest quarter?
Free cash flow was -48.02M reflecting a -60.95% change from the previous year.